(Q80799539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

Martti Huuhka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

6

Esa Leinonen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

Kaija Huuhka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1

Sami Anttila

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

5

Riikka Rontu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

Ari Illi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

7

Terho Lehtimäki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

14 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

113-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700596%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Role of the dopaminergic system in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

The effects of ECT on brain glucose: a pilot FDG PET study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

High but not low ECS stimulus intensity augments apomorphine-stimulated dopamine postsynaptic receptor functioning in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Apolipoprotein E polymorphism and response to electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021

Allelic discrimination using fluorogenic probes and the 5' nuclease assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500468

7 January 2021